Stock Earnings

Question 1

How did PRLD's recent EPS compare to expectations?

Accepted Answer

The most recent EPS for Prelude Therapeutics Inc is $-0.41, not beating expectations of $-0.44.

Question 2

How did Prelude Therapeutics Inc PRLD's revenue perform in the last quarter?

Accepted Answer

Prelude Therapeutics Inc revenue for the last quarter is $-0.41

Question 3

What is the revenue estimate for Prelude Therapeutics Inc?

Accepted Answer

According to 6 of Wall street analyst, the revenue estimate of Prelude Therapeutics Inc range from $36.75M to $0.0

Question 4

What's the earning quality score for Prelude Therapeutics Inc?

Accepted Answer

Prelude Therapeutics Inc has a earning quality score of B+/47.605923. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.

Question 5

When does Prelude Therapeutics Inc report earnings?

Accepted Answer

Prelude Therapeutics Inc next earnings report is expected in 2025-11-12

Question 6

What are Prelude Therapeutics Inc's expected earnings?

Accepted Answer

Prelude Therapeutics Inc expected earnings is $0.0, according to wall-street analysts.

Question 7

Did Prelude Therapeutics Inc beat earnings expectations?

Accepted Answer

Prelude Therapeutics Inc recent earnings of $0.0 does not beat expectations.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '25	$-0.44	$-0.41	-6.81%	MISSED
Q1 '25	$-0.47	$-0.42	-10.63%	MISSED
Q4 '24	$-0.47	$-0.38	-19.14%	MISSED
Q3 '24	$-0.48	$-0.43	-10.41%	MISSED
Q2 '24	$-0.43	$-0.46	+6.97%	BEAT

Prelude Therapeutics Inc (PRLD) Price

PRLD Stock Price Chart

Latest Earnings Results: Q2 '25

Historical Earnings

Earnings FAQ